Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
New York and Stockholm (ots/PRNewswire) - March 2011 Data Confirm Strong Treatment Effect of Chemosaturation Delcath Systems announced today that James F. Pingpank, MD, FACS, Associate Professor of Surgery at the University of Pittsburgh School of Medicine, will present updated investigator results from the Phase 3 ...
mehr